Asset
RECANACLOTIDE
Ironwood Pharmaceuticals Inc. Class A Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01712412 | phase2 | terminated | 2012-10-01 | 2014-02-01 | Ironwood Pharmaceuticals, Inc. | Phase 2a Study of IW-9179 to Treat Functional Dyspepsia |
| NCT02289846 | phase2 | completed | 2014-10-01 | 2015-12-01 | Ironwood Pharmaceuticals, Inc. | Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) |
FDA applications (0)
This company has no applications containing this asset.